More on DMRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:DMRA)
Delayed: 24.95 +3.72 (17.52%)
Prev. Close $21.23  
Open$21.51 
52 Wk High$ 
52 Wk Low$ 
Day High$25.90 
Day Low$21.51 
P/E N/A  
EPS$ 
Volume400,485 

Friends, Peers and Foes (?): (more...)

Jun 22, 2026 02:27 PM Form 144 Damora Therapeutics, Filed by: Firmani Lori
Jun 17, 2026 04:00 PM Form 8-K Damora Therapeutics, For: Apr 28
Jun 11, 2026 06:04 AM H.C. Wainwright Starts Damora Therapeutics (DMRA) at Buy
Jun 8, 2026 05:32 AM TD Cowen Starts Damora Therapeutics (DMRA) at Buy
Jun 1, 2026 08:00 AM Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026 06:53 AM Wedbush Starts Damora Therapeutics (DMRA) at Outperform
May 15, 2026 04:29 PM Form SCHEDULE 13G/A Damora Therapeutics, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:25 PM Form SCHEDULE 13G/A Damora Therapeutics, Filed by: Jain Global LLC
May 15, 2026 08:16 AM Form SCHEDULE 13G Damora Therapeutics, Filed by: Avoro Capital Advisors LLC
May 12, 2026 04:05 PM Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
View All Articles

Entities mentioned with DMRA

View All Entities